baglan moor healthcare plc
baglan moor healthcare plc Company Information
Company Number
03722614
Next Accounts
Sep 2025
Shareholders
law debenture trust corporation plc
semperian secretariat services ltd
Group Structure
View All
Industry
Hospital activities
Registered Address
third floor broad quay house, prince street, bristol, BS1 4DJ
Website
lawdeb.co.ukbaglan moor healthcare plc Estimated Valuation
Pomanda estimates the enterprise value of BAGLAN MOOR HEALTHCARE PLC at £4.2m based on a Turnover of £8m and 0.52x industry multiple (adjusted for size and gross margin).
baglan moor healthcare plc Estimated Valuation
Pomanda estimates the enterprise value of BAGLAN MOOR HEALTHCARE PLC at £3.9m based on an EBITDA of £1m and a 3.87x industry multiple (adjusted for size and gross margin).
baglan moor healthcare plc Estimated Valuation
Pomanda estimates the enterprise value of BAGLAN MOOR HEALTHCARE PLC at £3.7m based on Net Assets of £1.4m and 2.7x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Baglan Moor Healthcare Plc Overview
Baglan Moor Healthcare Plc is a live company located in bristol, BS1 4DJ with a Companies House number of 03722614. It operates in the hospital activities sector, SIC Code 86101. Founded in March 1999, it's largest shareholder is law debenture trust corporation plc with a 100% stake. Baglan Moor Healthcare Plc is a mature, mid sized company, Pomanda has estimated its turnover at £8m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Baglan Moor Healthcare Plc Health Check
Pomanda's financial health check has awarded Baglan Moor Healthcare Plc a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 4 areas for improvement. Company Health Check FAQs
4 Strong
2 Regular
4 Weak
Size
annual sales of £8m, make it larger than the average company (£4.7m)
£8m - Baglan Moor Healthcare Plc
£4.7m - Industry AVG
Growth
3 year (CAGR) sales growth of 9%, show it is growing at a similar rate (8.1%)
9% - Baglan Moor Healthcare Plc
8.1% - Industry AVG
Production
with a gross margin of 21.2%, this company has a higher cost of product (35.3%)
21.2% - Baglan Moor Healthcare Plc
35.3% - Industry AVG
Profitability
an operating margin of 12.7% make it more profitable than the average company (10%)
12.7% - Baglan Moor Healthcare Plc
10% - Industry AVG
Employees
with 106 employees, this is above the industry average (57)
- Baglan Moor Healthcare Plc
57 - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Baglan Moor Healthcare Plc
- - Industry AVG
Efficiency
resulting in sales per employee of £75.5k, this is equally as efficient (£75.5k)
- Baglan Moor Healthcare Plc
£75.5k - Industry AVG
Debtor Days
it gets paid by customers after 9 days, this is earlier than average (21 days)
9 days - Baglan Moor Healthcare Plc
21 days - Industry AVG
Creditor Days
its suppliers are paid after 11 days, this is quicker than average (31 days)
11 days - Baglan Moor Healthcare Plc
31 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Baglan Moor Healthcare Plc
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (42 weeks)
0 weeks - Baglan Moor Healthcare Plc
42 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 98.2%, this is a higher level of debt than the average (41.9%)
98.2% - Baglan Moor Healthcare Plc
41.9% - Industry AVG
BAGLAN MOOR HEALTHCARE PLC financials
Baglan Moor Healthcare Plc's latest turnover from March 2024 is £8 million and the company has net assets of £1.4 million. According to their latest financial statements, we estimate that Baglan Moor Healthcare Plc has 106 employees and maintains cash reserves of £41 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 7,999,000 | 8,879,000 | 5,188,000 | 6,160,000 | 5,806,000 | 5,700,000 | 5,513,000 | 5,725,000 | 5,608,000 | 5,699,000 | 5,551,000 | 5,988,000 | 5,019,000 | 3,709,000 | 3,640,000 |
| Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost Of Sales | 6,304,000 | 7,111,000 | 3,551,000 | 4,411,000 | 4,299,000 | 4,144,000 | 4,128,000 | 3,442,000 | 3,615,000 | 3,713,000 | 3,647,000 | 4,018,000 | 3,212,000 | 3,138,000 | 2,676,000 |
| Gross Profit | 1,695,000 | 1,768,000 | 1,637,000 | 1,749,000 | 1,507,000 | 1,556,000 | 1,385,000 | 2,283,000 | 1,993,000 | 1,986,000 | 1,904,000 | 1,970,000 | 1,807,000 | 571,000 | 964,000 |
| Admin Expenses | 682,000 | 595,000 | 542,000 | 538,000 | 538,000 | 494,000 | 529,000 | 512,000 | 363,000 | 394,000 | 352,000 | 477,000 | 457,000 | 426,000 | 467,000 |
| Operating Profit | 1,013,000 | 1,173,000 | 1,095,000 | 1,211,000 | 969,000 | 1,062,000 | 856,000 | 1,771,000 | 1,630,000 | 1,592,000 | 1,552,000 | 1,493,000 | 1,350,000 | 145,000 | 497,000 |
| Interest Payable | 6,973,000 | 7,817,000 | 4,996,000 | 3,963,000 | 5,033,000 | 5,695,000 | 6,023,000 | 4,984,000 | 4,781,000 | 5,719,000 | 6,296,000 | 6,218,000 | 7,682,000 | 7,048,000 | 4,220,000 |
| Interest Receivable | 8,953,000 | 7,470,000 | 3,952,000 | 3,680,000 | 4,496,000 | 5,271,000 | 5,261,000 | 4,154,000 | 4,054,000 | 5,226,000 | 5,769,000 | 6,062,000 | 7,302,000 | 5,815,000 | 6,578,000 |
| Pre-Tax Profit | 2,993,000 | 826,000 | 51,000 | 928,000 | 432,000 | 638,000 | 94,000 | 941,000 | 903,000 | 1,099,000 | 1,025,000 | 1,337,000 | 970,000 | -1,088,000 | 2,855,000 |
| Tax | -870,000 | -285,000 | -1,349,000 | -494,000 | -704,000 | -247,000 | -120,000 | -169,000 | -84,000 | -315,000 | 51,000 | -241,000 | 32,000 | 277,000 | -858,000 |
| Profit After Tax | 2,123,000 | 541,000 | -1,298,000 | 434,000 | -272,000 | 391,000 | -26,000 | 772,000 | 819,000 | 784,000 | 1,076,000 | 1,096,000 | 1,002,000 | -811,000 | 1,997,000 |
| Dividends Paid | 0 | 0 | 0 | 0 | 4,623,000 | 0 | 0 | 0 | 1,990,000 | 0 | 3,528,000 | 0 | 0 | 61,000 | 1,100,000 |
| Retained Profit | 2,123,000 | 541,000 | -1,298,000 | 434,000 | -4,895,000 | 391,000 | -26,000 | 772,000 | -1,171,000 | 784,000 | -2,452,000 | 1,096,000 | 1,002,000 | -872,000 | 897,000 |
| Employee Costs | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 132,000 | 124,000 | 122,000 | 116,000 | 0 |
| Number Of Employees | 4 | 3 | 2 | 2 | |||||||||||
| EBITDA* | 1,013,000 | 1,173,000 | 1,095,000 | 1,211,000 | 969,000 | 1,062,000 | 856,000 | 1,771,000 | 1,630,000 | 1,592,000 | 1,552,000 | 1,493,000 | 1,350,000 | 145,000 | 497,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 45,684,000 | 51,097,000 | 52,071,000 | 53,179,000 | 57,804,000 | 61,477,000 | 64,451,000 | 65,810,000 | 68,649,000 | 70,958,000 | 73,748,000 | 74,744,000 | 75,702,000 | 67,792,000 | 68,025,000 |
| Total Fixed Assets | 45,684,000 | 51,097,000 | 52,071,000 | 53,179,000 | 57,804,000 | 61,477,000 | 64,451,000 | 65,810,000 | 68,649,000 | 70,958,000 | 73,748,000 | 74,744,000 | 75,702,000 | 67,792,000 | 68,025,000 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 201,000 | 158,000 | 104,000 | 26,000 | 292,000 | 98,000 | 63,000 | 17,000 | 36,000 | 110,000 | 51,000 | 73,000 | 269,000 | 502,000 | 1,065,000 |
| Group Debtors | 4,696,000 | 4,480,000 | 2,079,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 400,000 | 0 |
| Misc Debtors | 7,639,000 | 3,140,000 | 2,677,000 | 6,026,000 | 4,776,000 | 4,170,000 | 3,248,000 | 3,840,000 | 3,524,000 | 2,868,000 | 1,388,000 | 4,309,000 | 1,696,000 | 983,000 | 1,278,000 |
| Cash | 41,000 | 10,476,000 | 13,564,000 | 13,274,000 | 11,865,000 | 14,996,000 | 15,685,000 | 12,818,000 | 11,942,000 | 13,696,000 | 11,372,000 | 10,500,000 | 10,381,000 | 9,931,000 | 8,732,000 |
| misc current assets | 17,863,000 | 3,800,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 30,440,000 | 22,054,000 | 18,424,000 | 19,326,000 | 16,933,000 | 19,264,000 | 18,996,000 | 16,675,000 | 15,502,000 | 16,674,000 | 12,811,000 | 14,882,000 | 12,346,000 | 11,816,000 | 11,075,000 |
| total assets | 76,124,000 | 73,151,000 | 70,495,000 | 72,505,000 | 74,737,000 | 80,741,000 | 83,447,000 | 82,485,000 | 84,151,000 | 87,632,000 | 86,559,000 | 89,626,000 | 88,048,000 | 79,608,000 | 79,100,000 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 201,000 | 766,000 | 24,000 | 24,000 | 404,000 | 406,000 | 659,000 | 321,000 | 15,000 | 194,000 | 99,000 | 367,000 | 24,000 | 87,000 | 0 |
| Group/Directors Accounts | 2,192,000 | 726,000 | 619,000 | 613,000 | 604,000 | 600,000 | 2,706,000 | 1,533,000 | 602,000 | 731,000 | 545,000 | 548,000 | 622,000 | 585,000 | 0 |
| other short term finances | 5,934,000 | 3,035,000 | 1,322,000 | 3,484,000 | 3,424,000 | 2,908,000 | 2,272,000 | 2,775,000 | 2,573,000 | 3,394,000 | 3,335,000 | 3,044,000 | 2,857,000 | 1,873,000 | 2,416,000 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 3,084,000 | 2,416,000 | 2,474,000 | 2,533,000 | 2,161,000 | 1,799,000 | 1,866,000 | 3,462,000 | 3,767,000 | 3,234,000 | 2,154,000 | 2,065,000 | 1,827,000 | 2,194,000 | 2,486,000 |
| total current liabilities | 11,411,000 | 6,943,000 | 4,439,000 | 6,654,000 | 6,593,000 | 5,713,000 | 7,503,000 | 8,091,000 | 6,957,000 | 7,553,000 | 6,133,000 | 6,024,000 | 5,330,000 | 4,739,000 | 4,902,000 |
| loans | 43,404,000 | 48,611,000 | 51,474,000 | 52,433,000 | 56,609,000 | 60,084,000 | 62,882,000 | 64,036,000 | 66,804,000 | 68,726,000 | 69,565,000 | 70,601,000 | 71,620,000 | 71,807,000 | 70,889,000 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 14,953,000 | 13,776,000 | 11,441,000 | 10,039,000 | 8,692,000 | 7,632,000 | 6,221,000 | 3,611,000 | 4,584,000 | 4,460,000 | 4,110,000 | 3,747,000 | 3,181,000 | 2,779,000 | 1,877,000 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 4,977,000 | 4,565,000 | 4,427,000 | 3,367,000 | 3,265,000 | 2,839,000 | 2,759,000 | 2,639,000 | 2,470,000 | 2,386,000 | 2,262,000 | 2,313,000 | 2,072,000 | 952,000 | 1,229,000 |
| total long term liabilities | 63,334,000 | 66,952,000 | 67,342,000 | 65,839,000 | 68,566,000 | 70,555,000 | 71,862,000 | 70,286,000 | 73,858,000 | 75,572,000 | 75,937,000 | 76,661,000 | 76,873,000 | 75,538,000 | 73,995,000 |
| total liabilities | 74,745,000 | 73,895,000 | 71,781,000 | 72,493,000 | 75,159,000 | 76,268,000 | 79,365,000 | 78,377,000 | 80,815,000 | 83,125,000 | 82,070,000 | 82,685,000 | 82,203,000 | 80,277,000 | 78,897,000 |
| net assets | 1,379,000 | -744,000 | -1,286,000 | 12,000 | -422,000 | 4,473,000 | 4,082,000 | 4,108,000 | 3,336,000 | 4,507,000 | 4,489,000 | 6,941,000 | 5,845,000 | -669,000 | 203,000 |
| total shareholders funds | 1,379,000 | -744,000 | -1,286,000 | 12,000 | -422,000 | 4,473,000 | 4,082,000 | 4,108,000 | 3,336,000 | 4,507,000 | 4,489,000 | 6,941,000 | 5,845,000 | -669,000 | 203,000 |
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | 1,013,000 | 1,173,000 | 1,095,000 | 1,211,000 | 969,000 | 1,062,000 | 856,000 | 1,771,000 | 1,630,000 | 1,592,000 | 1,552,000 | 1,493,000 | 1,350,000 | 145,000 | 497,000 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | -870,000 | -285,000 | -1,349,000 | -494,000 | -704,000 | -247,000 | -120,000 | -169,000 | -84,000 | -315,000 | 51,000 | -241,000 | 32,000 | 277,000 | -858,000 |
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | -655,000 | 1,944,000 | -2,300,000 | -3,641,000 | -2,873,000 | -2,017,000 | -1,905,000 | -2,542,000 | -1,727,000 | -1,251,000 | -3,939,000 | 1,459,000 | 7,990,000 | -691,000 | 70,368,000 |
| Creditors | -565,000 | 742,000 | 0 | -380,000 | -2,000 | -253,000 | 338,000 | 306,000 | -179,000 | 95,000 | -268,000 | 343,000 | -63,000 | 87,000 | 0 |
| Accruals and Deferred Income | 1,845,000 | 2,277,000 | 1,343,000 | 1,719,000 | 1,422,000 | 1,344,000 | 1,014,000 | -1,278,000 | 657,000 | 1,430,000 | 452,000 | 804,000 | 35,000 | 610,000 | 4,363,000 |
| Deferred Taxes & Provisions | 412,000 | 138,000 | 1,060,000 | 102,000 | 426,000 | 80,000 | 120,000 | 169,000 | 84,000 | 124,000 | -51,000 | 241,000 | 1,120,000 | -277,000 | 1,229,000 |
| Cash flow from operations | 2,490,000 | 2,101,000 | 4,449,000 | 5,799,000 | 4,984,000 | 4,003,000 | 4,113,000 | 3,341,000 | 3,835,000 | 4,177,000 | 5,675,000 | 1,181,000 | -5,516,000 | 1,533,000 | -65,137,000 |
| Investing Activities | |||||||||||||||
| capital expenditure | 0 | 2,300,000 | -1,900,000 | 0 | 0 | 0 | |||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | 0 | 2,300,000 | -1,900,000 | 0 | 0 | 0 | |||||||||
| Financing Activities | |||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 1,466,000 | 107,000 | 6,000 | 9,000 | 4,000 | -2,106,000 | 1,173,000 | 931,000 | -129,000 | 186,000 | -3,000 | -74,000 | 37,000 | 585,000 | 0 |
| Other Short Term Loans | 2,899,000 | 1,713,000 | -2,162,000 | 60,000 | 516,000 | 636,000 | -503,000 | 202,000 | -821,000 | 59,000 | 291,000 | 187,000 | 984,000 | -543,000 | 2,416,000 |
| Long term loans | -5,207,000 | -2,863,000 | -959,000 | -4,176,000 | -3,475,000 | -2,798,000 | -1,154,000 | -2,768,000 | -1,922,000 | -839,000 | -1,036,000 | -1,019,000 | -187,000 | 918,000 | 70,889,000 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | |||||||||||||||
| interest | 1,980,000 | -347,000 | -1,044,000 | -283,000 | -537,000 | -424,000 | -762,000 | -830,000 | -727,000 | -493,000 | -527,000 | -156,000 | -380,000 | -1,233,000 | 2,358,000 |
| cash flow from financing | 1,138,000 | -1,389,000 | -4,159,000 | -4,390,000 | -3,492,000 | -4,692,000 | -1,246,000 | -2,465,000 | -3,599,000 | -1,853,000 | -1,275,000 | -1,062,000 | 5,966,000 | -273,000 | 74,969,000 |
| cash and cash equivalents | |||||||||||||||
| cash | -10,435,000 | -3,088,000 | 290,000 | 1,409,000 | -3,131,000 | -689,000 | 2,867,000 | 876,000 | -1,754,000 | 2,324,000 | 872,000 | 119,000 | 450,000 | 1,199,000 | 8,732,000 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | -10,435,000 | -3,088,000 | 290,000 | 1,409,000 | -3,131,000 | -689,000 | 2,867,000 | 876,000 | -1,754,000 | 2,324,000 | 872,000 | 119,000 | 450,000 | 1,199,000 | 8,732,000 |
baglan moor healthcare plc Credit Report and Business Information
Baglan Moor Healthcare Plc Competitor Analysis
Perform a competitor analysis for baglan moor healthcare plc by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other mid companies, companies in BS1 area or any other competitors across 12 key performance metrics.
baglan moor healthcare plc Ownership
BAGLAN MOOR HEALTHCARE PLC group structure
Baglan Moor Healthcare Plc has no subsidiary companies.
Ultimate parent company
SEMPERIAN PPP INVESTMENT PARTNERS HOLDIN
#0062968
2 parents
BAGLAN MOOR HEALTHCARE PLC
03722614
baglan moor healthcare plc directors
Baglan Moor Healthcare Plc currently has 3 directors. The longest serving directors include Mr Harvey Pownall (May 2018) and Mr Daniel North (May 2019).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Harvey Pownall | United Kingdom | 58 years | May 2018 | - | Director |
| Mr Daniel North | 36 years | May 2019 | - | Director | |
| Mr Louis Falero | England | 48 years | Nov 2022 | - | Director |
P&L
March 2024turnover
8m
-10%
operating profit
1m
-14%
gross margin
21.2%
+6.42%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
1.4m
-2.85%
total assets
76.1m
+0.04%
cash
41k
-1%
net assets
Total assets minus all liabilities
baglan moor healthcare plc company details
company number
03722614
Type
Public limited with Share Capital
industry
86101 - Hospital activities
incorporation date
March 1999
age
26
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
March 2024
previous names
baglan moor healthcare plc (October 2009)
baglan moor healthcare limited (May 2000)
accountant
-
auditor
PRICEWATERHOUSECOOPERS LLP
address
third floor broad quay house, prince street, bristol, BS1 4DJ
Bank
-
Legal Advisor
-
baglan moor healthcare plc Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 1 charges/mortgages relating to baglan moor healthcare plc. Currently there are 1 open charges and 0 have been satisfied in the past.
baglan moor healthcare plc Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for BAGLAN MOOR HEALTHCARE PLC. This can take several minutes, an email will notify you when this has completed.
baglan moor healthcare plc Companies House Filings - See Documents
| date | description | view/download |
|---|
